---
schema_version: "secwatch.filing_event.v1"
accession: "0001323885-25-000002"
form_type: "8-K"
ticker: "ATRC"
cik: "0001323885"
company_name: "AtriCure, Inc."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T02:55:55.305510+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# AtriCure reports preliminary Q4 revenue $124.3M (+17%); guides 2025 revenue $517-527M

## Summary
- Preliminary Q4 2024 revenue $124.3M (+17% YoY as reported and constant currency).
- U.S. revenue $101.6M (+14%), international $22.7M (+28%) in Q4.
- FY2024 revenue $465.3M (+17%); expects adj. EBITDA $26M-$29M and adj. EPS loss $0.74-$0.80.
- 2025 guidance: revenue $517M-$527M, adj. EBITDA $40M-$44M, modest cash flow generation.
- Analyst & Investor Day scheduled for March 26, 2025 at Mason, Ohio headquarters.

## SEC filing metadata
- accession: 0001323885-25-000002
- form_type: 8-K
- ticker: ATRC
- cik: 0001323885
- company_name: AtriCure, Inc.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1323885/000132388525000002/0001323885-25-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1323885/000132388525000002/atrc-20250113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001323885-25-000002
- JSON: https://secwatch.observer/filing/0001323885-25-000002.json
- Plain text: https://secwatch.observer/filing/0001323885-25-000002.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.